platoseedplatoseed
Tradewind translates scientific insight into innovative ways of…
Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.
Tradewind BioScience is a Bay Area biotech company focused on developing novel therapeutics to eliminate metastatic cancer, with an emphasis on biomarker-driven companion diagnostics to identify patients who will benefit from their medicines.
The company combines drug development with companion diagnostics, using biomarker identification to select patients most likely to respond to its targeted therapeutics and translating science from founders into novel drugs.
Who it’s for: Pharmaceutical/biotech researchers, oncology drug developers, and biopharma companies seeking targeted cancer therapeutics with companion diagnostics
funding/traction not explicitly stated; mentions mission and formation to translate science into drugs
As a full-time founder at Tradewind, my focus is on translating novel science into viable and novel therapeutic approaches and relating the value of our mission. This calls on skills and knowledge developed through 25 years of cancer research experience and more recent experience in business oriented rolls. Skills/Experience - PhD level cancer biologist - Management of a research team - Patent portfolio management and IP agreements - Scientific data analysis and interpretation
Computational antibody design
Population health analytics powered by wastewater.
